icon

DeepChek® Assay Protease / Reverse Transcriptase Genotyping and Drug Resistance

An HIV-1 PR/RT genotyping assay for antiretroviral susceptibility workflows covering protease inhibitors and reverse-transcriptase inhibitor drug classes.

HIV Genotyping & Drug Resistance

Protease / Reverse Transcriptase

CE-IVDRUO

The PR/RT assay combines target-specific PCR reagents with HIV analysis software and is positioned for laboratories using either Sanger or next-generation sequencing platforms.

Sequencing workflow HIV-1 DeepChek portfolio
DeepChek Assay Protease / Reverse Transcriptase Genotyping and Drug Resistance

Key Details

  • Supports HIV-1 genotyping for protease and reverse transcriptase regions.
  • Provides susceptibility context for PI, NRTI, and NNRTI drug classes.
  • Compatible with Sanger and NGS sequencing approaches.
  • Pairs assay reagents with DeepChek HIV or ViroScore-HIV reporting workflows.

Workflow Snapshot

Target regionProtease and reverse transcriptase
SequencingSanger or NGS compatible
NGS reportingDeepChek-HIV CE-IVD
Sanger reportingViroScore-HIV CE-IVD

Ordering Information

ProductReference
DeepChek Assay Protease / Reverse Transcriptase Genotyping and Drug Resistance (CE-IVD)121A24
DeepChek Assay Protease / Reverse Transcriptase Genotyping and Drug Resistance (RUO)101B24
DeepChek HIV Software (CE-IVD)S-12-023 (HL)
ViroScore-HIV Annual Software License (CE-IVD)S-09-014

Implementation Note

A strong fit for laboratories focused on the most established HIV-1 PR/RT drug resistance regions.

Back To HIV Portfolio

Related HIV Assays